12 Health Care Stocks Moving In Thursday's After-Market Session

週四盤後交易時段，12只醫療保健股走勢

Benzinga · 2023/09/22 05:31

Regulus Therapeutics (NASDAQ:RGLS) stock increased by 12.4% to $1.45 during Thursday's after-market session. The company's market cap stands at $28.2 million.
SeqLL (NASDAQ:SQL) shares moved upwards by 10.34% to $15.79. The company's market cap stands at $6.0 million.
bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 9.43% to $1.16. The market value of their outstanding shares is at $10.1 million.
Enveric Biosciences (NASDAQ:ENVB) shares increased by 9.05% to $2.65. The market value of their outstanding shares is at $5.7 million.
Blue Water Biotech (NASDAQ:BWV) shares rose 8.67% to $0.61. Trading volume for this security closed at 129.4K, accounting for 130.5% of its average full-day volume over the last 100 days. The company's market cap stands at $9.7 million.
China Pharma Holding (AMEX:CPHI) stock rose 7.01% to $0.14. At the close, China Pharma Holding's trading volume reached 65.8K shares. This is 7.2% of its average volume over the last 100 days. The company's market cap stands at $1.6 million.

Baudax Bio (NASDAQ:BXRX) shares decreased by 10.1% to $0.31 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
Surrozen (NASDAQ:SRZN) stock declined by 6.49% to $0.43. The market value of their outstanding shares is at $13.0 million.
TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 6.45% to $0.65. Today's trading volume for this security ended up closing at 583.3K shares, which is 103.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 million.
IGC Pharma (AMEX:IGC) stock fell 5.33% to $0.37. The market value of their outstanding shares is at $19.9 million.
Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 4.63% to $2.89. The market value of their outstanding shares is at $540.3 million.
TRACON Pharma (NASDAQ:TCON) stock decreased by 4.57% to $0.21. The market value of their outstanding shares is at $6.4 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Regulus Therapeutics (NASDAQ:RGLS) stock increased by 12.4% to $1.45 during Thursday's after-market session. The company's market cap stands at $28.2 million.
SeqLL (NASDAQ:SQL) shares moved upwards by 10.34% to $15.79. The company's market cap stands at $6.0 million.
bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 9.43% to $1.16. The market value of their outstanding shares is at $10.1 million.
Enveric Biosciences (NASDAQ:ENVB) shares increased by 9.05% to $2.65. The market value of their outstanding shares is at $5.7 million.
Blue Water Biotech (NASDAQ:BWV) shares rose 8.67% to $0.61. Trading volume for this security closed at 129.4K, accounting for 130.5% of its average full-day volume over the last 100 days. The company's market cap stands at $9.7 million.
China Pharma Holding (AMEX:CPHI) stock rose 7.01% to $0.14. At the close, China Pharma Holding's trading volume reached 65.8K shares. This is 7.2% of its average volume over the last 100 days. The company's market cap stands at $1.6 million.

雷古勒斯療法 納斯達克股票代碼：RGLS）股價在週四的盤後交易時段上漲了12.4％，至1.45美元。該公司的市值爲2,820萬美元。
SeqLL 納斯達克股票代碼：SQL）股價上漲10.34％，至15.79美元。該公司的市值爲600萬美元。
生物親和性技術 納斯達克股票代碼：BIAF）股價上漲9.43％，至1.16美元。他們流通股的市值爲1,010萬美元。
恩維裏克生物科學 納斯達克股票代碼：ENVB）股價上漲9.05％，至2.65美元。他們流通股的市值爲570萬美元。
藍水生物科技 納斯達克股票代碼：BWV）股價上漲8.67％，至0.61美元。該證券的交易量收於12.94萬，佔其過去100天平均全天交易量的130.5％。該公司的市值爲970萬美元。
中國醫藥控股 美國證券交易所股票代碼：CPHI）股價上漲7.01％，至0.14美元。收盤時，中國醫藥控股的交易量達到6.58萬股。這是其過去100天平均交易量的7.2％。該公司的市值爲160萬美元。

Baudax Bio (NASDAQ:BXRX) shares decreased by 10.1% to $0.31 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
Surrozen (NASDAQ:SRZN) stock declined by 6.49% to $0.43. The market value of their outstanding shares is at $13.0 million.
TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 6.45% to $0.65. Today's trading volume for this security ended up closing at 583.3K shares, which is 103.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 million.
IGC Pharma (AMEX:IGC) stock fell 5.33% to $0.37. The market value of their outstanding shares is at $19.9 million.
Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 4.63% to $2.89. The market value of their outstanding shares is at $540.3 million.
TRACON Pharma (NASDAQ:TCON) stock decreased by 4.57% to $0.21. The market value of their outstanding shares is at $6.4 million. See Also:

Baudax Bio 納斯達克股票代碼：BXRX）股價在週四的盤後交易時段下跌10.1％，至0.31美元。他們流通股的市值爲280萬美元。
Surroze 納斯達克股票代碼：SRZN）股價下跌6.49％，至0.43美元。他們流通股的市值爲1,300萬美元。
TransCode 治療學 納斯達克股票代碼：RNAZ）股價下跌6.45％，至0.65美元。該證券今天的交易量最終收於58.33萬股，佔其過去100天平均交易量的103.7％。他們流通股的市值爲130萬美元。
IGC 製藥 美國證券交易所股票代碼：IGC）股價下跌5.33％，至0.37美元。他們流通股的市值爲1,990萬美元。
Taysha 基因療法 納斯達克股票代碼：TSHA）股價下跌4.63％，至2.89美元。他們流通股的市值爲5.403億美元。
特拉康製藥 納斯達克股票代碼：TCON）股價下跌4.57％，至0.21美元。他們流通股的市值爲640萬美元。 另請參閱：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

風險及免責聲明